Abbreviations
- UM:
-
Uveal melanoma
- CM:
-
Cutaneous melanoma
References
Cerami E, Gao J, Dogrusoz U et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401–404
Durinck S, Ho C, Wang NJ et al (2011) Temporal dissection of tumorigenesis in primary cancers. Cancer Discov 1:137–143
Kurokawa R, Kim P, Kawamoto T et al (2013) Intramedullary and retroperitoneal melanocytic tumor associated with congenital blue nevus and nevus flammeus: an uncommon combination of neurocutaneous melanosis and phacomatosis pigmentovascularis. Neurol Med Chir 53:730–734
Kusters-Vandevelde HV, Kusters B, van Engen-van Grunsven AC et al (2015) Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects. Brain Pathol 25:209–226
Martin M, Masshofer L, Temming P et al (2013) Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 45:933–936
Network CGAR. (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209
Nik-Zainal S, Davies H, Staaf J et al (2016) Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534:47–54
Robinson JT, Thorvaldsdóttir H, Winckler W et al (2011) Integrative genomics viewer. Nat Biotechnol 29:24–26
Thomas AC, Zeng Z, Rivière JB et al (2016) Mosaic activating mutations in GNA11 and GNAQ are associated with phakomatosis pigmentovascularis and extensive dermal melanocytosis. J Invest Dermatol 136:770–778
van de Nes JAP, Koelsche C, Gessi M et al (2017) Activating CYSLTR2 and PLCB4 mutations in primary leptomeningeal melanocytic tumors. J Invest Dermatol 137:2033–2035
Acknowledgements
We would like to thank the patient for allowing us to undertake these analyses and to share these data. We thank Dr. J. Koten for critically revising the manuscript. We are grateful to Marcel Jeunink for the assistance with the molecular analyses.
Funding
This work was supported by Cancer Research UK and the Wellcome Trust.
Author information
Authors and Affiliations
Contributions
HK, MG, and ML designed the study, made substantial contributions to the acquisition and interpretation of data and wrote the manuscript. RR and DJA made substantial contributions to the acquisition and interpretation of molecular data, and were major contributors in writing the manuscript. MR, RB, CP, and WB contributed to the acquisition and interpretation of molecular data and WB and HK reviewed the histology. All authors were involved in drafting the manuscript or in its critical revisions, and participated sufficiently to take public responsibility for appropriate portions of the content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflicts of interest.
Ethical approval and consent to participate
Ethical approval was sought from the Commisie Mensgebonden Onderzoek, Nijmegen, Netherlands (CMO, ref.nr/Dossiernummer: 2016–2863). Written informed consent was obtained from the patient for publication of this case report and its accompanying images. A copy of the written consent is available for review by the editor.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Küsters-Vandevelde, H.V.N., Germans, M.R., Rabbie, R. et al. Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma. Brain Tumor Pathol 35, 127–130 (2018). https://doi.org/10.1007/s10014-018-0308-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10014-018-0308-1